Structural understanding of efflux-mediated drug resistance: potential routes to efflux inhibition.
about
Efflux-mediated drug resistance in bacteria: an updateDrug export pathway of multidrug exporter AcrB revealed by DARPin inhibitorsThe interaction of N-acylhomoserine lactone quorum sensing signaling molecules with biological membranes: implications for inter-kingdom signaling.Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.Efflux-mediated antimicrobial resistance.Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review.Potential applications of designed ankyrin repeat proteins in diagnostics and therapeutics.Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives.3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity.Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA.Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.A model of a transmembrane drug-efflux pump from Gram-negative bacteria.Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
P2860
Q24609407-C2FE0C50-46EC-4E74-BF8F-D5D1D878FB2EQ27334925-63EE20C2-B3A1-4094-8740-C707251E45DAQ33728057-1A394C15-9C05-408F-975D-3778DF7FBC18Q34697137-A1E11EE5-12F4-4A05-8E7C-8B2B4B06459DQ36138147-F1A572EB-27D1-40B2-AA86-78D17672CA6CQ37573748-9281599C-A2CC-477C-B000-B5237DB45249Q37854074-1BB68788-E6DE-449E-884C-26148FA6819EQ38089263-80DC5696-BDD4-4179-A38D-4BEED499D410Q38154347-9B6EE47B-919E-44F6-96B2-AEA76D33768EQ38901475-4F110898-2E57-437F-B802-DB184A3BE15EQ39734137-3A7F3FB3-FAEB-44E8-B482-CE399FEB768DQ42948655-1CB88470-7FA0-4975-8D6C-C8A3FC3F6314Q48552041-F993F8D6-C006-4485-96F3-E655B623C000Q52952104-2FCF3658-6CCC-4E7C-94D2-03A2CAA9398A
P2860
Structural understanding of efflux-mediated drug resistance: potential routes to efflux inhibition.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Structural understanding of ef ...... l routes to efflux inhibition.
@ast
Structural understanding of ef ...... l routes to efflux inhibition.
@en
type
label
Structural understanding of ef ...... l routes to efflux inhibition.
@ast
Structural understanding of ef ...... l routes to efflux inhibition.
@en
prefLabel
Structural understanding of ef ...... l routes to efflux inhibition.
@ast
Structural understanding of ef ...... l routes to efflux inhibition.
@en
P2093
P1476
Structural understanding of ef ...... l routes to efflux inhibition.
@en
P2093
Adrian R Walmsley
Kenneth S McKeegan
M Ines Borges-Walmsley
P304
P356
10.1016/J.COPH.2004.07.002
P577
2004-10-01T00:00:00Z